Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Maine Medical Equipment Providers Back Congressional Bill to Repeal Flawed Medicare Bidding Program

May 16, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

PORTLAND, Maine, May 16, 2011 /PRNewswire-USNewswire/ -- Maine home medical equipment and services (HME) providers support H.R. 1041, a bipartisan bill in Congress to repeal the controversial Medicare "competitive" bidding program for home medical equipment and services.   "If...

Massachusetts Home Medical Equipment Providers Back Federal Legislation to Repeal Controversial Medicare Bidding Program

May 16, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

BOSTON, May 16, 2011 /PRNewswire-USNewswire/ -- Massachusetts providers of home medical equipment and services (HME) support H.R. 1041, a bipartisan bill in Congress to repeal the flawed, controversial Medicare "competitive" bidding program for medically required equipment and services....

Lilly Oncology to Unveil Data From More Than 30 Studies at ASCO

May 16, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, May 16, 2011 /- Eli Lilly and Company (NYSE: LLY ) will present data from more than 30 studies at the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill., from June 3 – 7, 2011, including results from PARAMOUNT, a Phase III study of...

Advertisement

MedImmune To Present Eight Abstracts on Projects Regarding Thoracic and Respiratory Issues at the Annual American Thoracic Society International Conference

May 13, 2011 6:39 am | by Bio-Medicine.Org | News | Comments

GAITHERSBURG, Md., May 13, 2011 /- MedImmune announced today it will present eight abstracts at the American Thoracic Society (ATS) International Conference in Denver, CO, May 13-18, 2011.  "These data advance our understanding of thoracic diseases, highlighting our continued...

Mylan Launches Generic Version of Risperdal® M-Tab®

May 13, 2011 4:47 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, May 13, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Risperidone Orally Disintegrating Tablets (ODT), 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg, the generic version of Ortho-McNeil's Risperdal® M-Tab®, a...

Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society

May 11, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 11, 2011 /- Amira Pharmaceuticals, Inc. announced today that it will present preclinical data on AM152, an LPA1 receptor antagonist, during the Annual Meeting of the American Thoracic Society (ATS) in Denver, Colorado.  The poster, titled "The LPA1 Antagonist, AM152,...

Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation

May 10, 2011 5:34 am | by Boston Scientific | News | Comments

Company sponsors additional efforts to promote education and awareness of severe asthma

Insmed Announces First Quarter 2011 Financial Results

May 10, 2011 4:32 am | by Bio-Medicine.Org | News | Comments

MONMOUTH JUNCTION, N.J., May 10, 2011 /- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for the first quarter ended March 31, 2011. Key Recent Highlights: Received Food and Drug Administration (FDA) clearance of Investigational New Drug (IND)...

Advertisement

Huntsville Memorial Hospital Selects Surgical Information Systems to Increase Safety, Generate Cost Savings

May 10, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

ATLANTA, May 10, 2011 /- Surgical Information Systems ("SIS") announced today that Huntsville Memorial Hospital in Huntsville, TX, selected SIS' surgical solution to automate its perioperative department, interfacing with the hospital's current MEDITECH system to provide patient care...

Generex Biotechnology Corporation CEO Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com

May 9, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, May 9, 2011 /- Generex Biotechnology Corporation ( www.generex.com ) (OTC:GNBT) announced that their May 5th RetailInvestorConferences.com presentation is available for on-demand viewing. LINK: www.retailinvestorconferences.com >Click the red "register/ watch event now"...

Former NBA Star Allan Houston Joins "Apply Yourself!" Campaign to Raise Awareness of Osteoarthritis Hand and Knee Pain

May 9, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., May 9, 2011 /- Endo Pharmaceuticals, a leading healthcare solutions company, today announced the launch of the "Apply Yourself!" Campaign, created to encourage people suffering from osteoarthritis (OA) hand and knee pain to make pain relief a top personal priority....

Acton Pharma names Newman, Phair as new execs

May 6, 2011 11:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Acton Pharmaceuticals Inc., a respiratory therapeutics firm in Marlborough, has appointed two new executives in naming Kenneth Newman as executive vice president, chief medical officer, and Thomas Phair as senior vice president, chief financial officer.

American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates

May 5, 2011 2:32 pm | by Bio-Medicine.Org | News | Comments

SHIRLEY, N.Y., May 5, 2011 /- American Regent is conducting a nationwide voluntary recall to the consumer and user level of the following product: Caffeine & Sodium Benzoate Injection, USP, 250 mg/mL, 2 mL Single Dose Vial, NDC # 0517-2502-10, Lot # 0084,  Exp Date...

Advertisement

Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence

May 5, 2011 2:32 pm | by Bio-Medicine.Org | News | Comments

OCEANSIDE, Calif., May 5, 2011 /PRNewswire-USNewswire/ -- For Judith Talnadge, a power wheelchair provided through Medicare is the difference between living independently in her apartment, with opportunities to visit with friends and engage in the community, or being confined to a nursing...

Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products

May 5, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., May 5, 2011 /- Pearl Therapeutics Inc. made three presentations at the Respiratory Drug Delivery Europe (RDD Europe 2011) meeting in Berlin this week elucidating the tunability, versatility and universality of the Company's porous particle-based metered dose inhaler...

New algorithm significantly improves imaging for full-body MRIs

May 4, 2011 10:37 pm | by EurekAlert | News | Comments

(American Roentgen Ray Society) A new study reveals an improved algorithm that can dramatically improve how radiologists capture and interpret full-body MRIs, particularly in the abdominal region.

Aires Pharmaceuticals Appoints Edwin L. Parsley as Chief Medical Officer

May 4, 2011 8:40 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 4, 2011 /- Aires Pharmaceuticals, Inc. today announced the hiring of Ed Parsley, D.O. as Chief Medical Officer.  Dr. Parsley will fill a key role on Aires' leadership team and will be responsible for all clinical development activities for Aironite™, the...

Plato BioPharma Presenting Poster at the American Thoracic Society Conference

May 4, 2011 8:40 am | by Bio-Medicine.Org | News | Comments

WESTMINSTER, Colo., May 4, 2011 /- Plato BioPharma, Inc. (PBI) and Gilead Sciences, Inc. will be jointly presenting a thematic poster at the "Novel Therapeutics in Pulmonary Fibrosis" session at the 2011 American Thoracic Society (ATS) International Conference in Denver, Colorado on May...

Delay of Medicare Bidding Program for Home Medical Equipment Underscores Severe Problems with Program; Support Surges for Bipartisan Bill to Repeal the Bid Program

May 4, 2011 8:40 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, May 4, 2011 /PRNewswire-USNewswire/ -- The delay in round two of Medicare's controversial "competitive" bidding program for home medical equipment and services underscores that program's severe design flaws. Opposition to the program continues to build among patient and...

Via Oncology Pathways Now Incorporate Advance Care Planning Decision Support

May 4, 2011 8:40 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, May 4, 2011 /- The most recent release of Via Oncology Pathways from D3 Oncology Solutions (D3) now includes decision support for advance care planning to encourage early discussions between oncologists and their patients about the disease, treatment intent and likely...

GenVec to Host First Quarter 2011 Earnings Call and Webcast

May 3, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

GAITHERSBURG, Md., May 3, 2011 /- GenVec, Inc. (Nasdaq: GNVCD) announced that it will release financial results for the first quarter ended March 31, 2011 on Monday, May 9, 2011 after market close.  GenVec will hold a conference call at 10:00 a.m. EDT on Tuesday, May 10, 2011 to...

Phreesia Helps Practices Manage Patients with Uncontrolled Asthma

May 3, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 3, 2011 /- Phreesia, the patient check-in company, announced the release of an asthma control assessment to all primary care physicians and pediatrics practices in its network. The screening tool is part of Phreesia's automated patient check-in solution and, through a series...

Boston Scientific Announces CE Mark Approval and First Use of Blazerâ„¢ Open-Irrigated Catheter in Europe

May 3, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., May 3, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced CE Mark approval and first use in Europe of its Blazer™ Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as...

GenerationOne Selected by Cincinnati Children's Hospital Medical Center for Mobile Health Pilot with Teen Asthmatics

May 3, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

MIAMI, May 3, 2011 /- GenerationOne and Cincinnati Children's Hospital Medical Center collaborated on a 14-month clinical trial for testing mobile technology in aiding the management of teenagers with Asthma. "Mobile phones represent an appealing technology for tailoring interventions and...

Generex Biotechnology Corporation CEO to Present Live, Online at RetailInvestorConferences.com on May 5th

May 2, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 2, 2011 /- Generex Biotechnology Corporation ( www.generex.com ) (OTC: GNBT) today announced that Mark Fletcher, CEO, will present at RetailInvestorConferences.com. DATE: May 5th, 2011 TIME:  11:00 AM EDT LINK: www.retailinvestorconferences.com >Click the red...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading